1. Home
  2. ORMP vs ASRT Comparison

ORMP vs ASRT Comparison

Compare ORMP & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORMP
  • ASRT
  • Stock Information
  • Founded
  • ORMP 2002
  • ASRT 1995
  • Country
  • ORMP United States
  • ASRT United States
  • Employees
  • ORMP N/A
  • ASRT N/A
  • Industry
  • ORMP Biotechnology: Pharmaceutical Preparations
  • ASRT Biotechnology: Pharmaceutical Preparations
  • Sector
  • ORMP Health Care
  • ASRT Health Care
  • Exchange
  • ORMP Nasdaq
  • ASRT Nasdaq
  • Market Cap
  • ORMP 90.7M
  • ASRT 85.1M
  • IPO Year
  • ORMP N/A
  • ASRT 1997
  • Fundamental
  • Price
  • ORMP $2.17
  • ASRT $0.80
  • Analyst Decision
  • ORMP Hold
  • ASRT Strong Buy
  • Analyst Count
  • ORMP 1
  • ASRT 4
  • Target Price
  • ORMP N/A
  • ASRT $3.19
  • AVG Volume (30 Days)
  • ORMP 110.4K
  • ASRT 337.3K
  • Earning Date
  • ORMP 03-05-2025
  • ASRT 03-10-2025
  • Dividend Yield
  • ORMP N/A
  • ASRT N/A
  • EPS Growth
  • ORMP N/A
  • ASRT N/A
  • EPS
  • ORMP 0.11
  • ASRT N/A
  • Revenue
  • ORMP N/A
  • ASRT $125,763,000.00
  • Revenue This Year
  • ORMP N/A
  • ASRT N/A
  • Revenue Next Year
  • ORMP N/A
  • ASRT $1.84
  • P/E Ratio
  • ORMP $20.01
  • ASRT N/A
  • Revenue Growth
  • ORMP N/A
  • ASRT N/A
  • 52 Week Low
  • ORMP $2.00
  • ASRT $0.73
  • 52 Week High
  • ORMP $3.67
  • ASRT $1.80
  • Technical
  • Relative Strength Index (RSI)
  • ORMP 36.05
  • ASRT 39.72
  • Support Level
  • ORMP $2.12
  • ASRT $0.78
  • Resistance Level
  • ORMP $2.27
  • ASRT $0.83
  • Average True Range (ATR)
  • ORMP 0.07
  • ASRT 0.03
  • MACD
  • ORMP -0.01
  • ASRT 0.00
  • Stochastic Oscillator
  • ORMP 22.73
  • ASRT 4.57

About ORMP Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.

About ASRT Assertio Holdings Inc.

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

Share on Social Networks: